1-13 of 13
Aleksandr Kulagin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplants for Patients with Hodgkin disease: A Comparative Study of the LWP EBMT

Juan Montoro, Ariane Boumendil, Hervé Finel, Stefania Bramanti, Luca Castagna, Sr., Didier Blaise, Alida Dominietto, Aleksandr Kulagin, Sr., Ibrahim Yakoub-Agha, Abdelghani Tbakhi, Carlos Solano, Sebastian Giebel, Zafer Gulbas, Dolores Caballero, Jose A. Perez-Simon, Jose Luis Diez Martin, Paolo Corradini, Yener Koc, Gerard Socié, Mutlu Arat, Manuel Jurado, Arancha Bermudez, Hélène Labussière-Wallet, Marta Villalba, Fabio Ciceri, Montserrat Rovira, Arnon Nagler, Anna Maria Sureda Balari, Bertram Glass
Journal: Blood
Blood (2023) 142 (Supplement 1): 4975.
https://doi.org/10.1182/blood-2023-179829
Published: 2023
Journal Articles

Post-Transplant Cyclophosphamide, Tacrolimus or Cyclosporine a and Mycophenolate Mofetil Compared to Anti-Thymocyte Globulin tacrolimus or Cyclosporine a and Methotrexate Combinations As Graft- versus -Host Disease Prophylaxis Post Allogeneic Stem Cell Transplantation from Sibling and Unrelated Donors in Patients with Acute Myeloid Leukemia: a Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Arnon Nagler, Myriam Labopin, Thomas Schroeder, Rose-Marie Hamladji, Laimonas Griskevicius, Urpu Salmenniemi, Alessandro Rambaldi, Stephan Mielke, Aleksandr Kulagin, Sr., Jakob R. Passweg, Peter Dreger, Tobias Gedde-Dahl, Edouard Forcade, Grzegorz Helbig, Matthias Stelljes, Cristina Castilla-Llorente, Alexandros Spyridonidis, Bipin N. Savani, Eolia Brissot, Fabio Ciceri, Mohamad Mohty
Journal: Blood
Blood (2023) 142 (Supplement 1): 2181.
https://doi.org/10.1182/blood-2023-174821
Published: 2023
Journal Articles

How Much Have Post-Transplant Outcomes Improved Since 2000 for Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia in First Remission? a Study from the EBMT Acute Leukemia Working Party

Ali Bazarbachi, Myriam Labopin, Iman Abou Dalle, Ibrahim Yakoub-Agha, Regis Peffault De Latour, Thomas Schroeder, Didier Blaise, Xavier Poire, Marie Balsat, Urpu Salmenniemi, Nicolaus Kröger, Aleksandr Kulagin, Sr., Eva Wagner Drouet, Depei Wu, Eolia Brissot, Arnon Nagler, Sebastian Giebel, Fabio Ciceri, Mohamad Mohty
Journal: Blood
Blood (2023) 142 (Supplement 1): 2234.
https://doi.org/10.1182/blood-2023-179578
Published: 2023
Journal Articles

UM171 Expanded Cord Blood Transplantation Outcomes Compare Favorably to All Different Stem Cell Sources: An EBMT Registry Case-Control Analysis

Sandra Cohen, Myriam Labopin, Nadia M. Bambace, Imran Ahmad, Maude Dumont-Lagacé, Fabio Ciceri, Donal P McLornan, Hélène Labussière-Wallet, Nicolaus Kröger, Regis Peffault De Latour, Yves Chalandon, Edouard Forcade, Thomas Cluzeau, Pavel Jindra, Aleksandr Kulagin, Sr., Jean Roy, Sylvie Lachance, Frederic Barabe, Pierre Caudrelier, Ibrahim Yakoub-Agha, Mohamad Mohty
Journal: Blood
Blood (2023) 142 (Supplement 1): 4977.
https://doi.org/10.1182/blood-2023-173727
Published: 2023
Journal Articles

Mismatched Unrelated Donor Transplantation with Ptcy-Based Gvhd Prophylaxis Is Associated with Better Survival Than Double Unit Umbilical Cord Blood Transplantation in Patients with AML in First CR: A Study from the ALWP of the EBMT

Frederic Baron, Myriam Labopin, Jurjen Versluis, Jan Vydra, Peter A. Von Dem Borne, Emma Nicholson, Didier Blaise, Stephen Robinson, Jr., Aleksandr Kulagin, Sr., Claude-Éric Bulabois, Montserrat Rovira, Patrice Chevallier, Édouard Forcade, Jenny Louise Byrne, Jaime Sanz Caballer, Annalisa Ruggeri, Mohamad Mohty, Fabio Ciceri
Journal: Blood
Blood (2023) 142 (Supplement 1): 2233.
https://doi.org/10.1182/blood-2023-186293
Published: 2023
Journal Articles

Alternative Donor Transplantation for Severe Aplastic Anemia: A Comparative Study of the Saawp EBMT

Juan Montoro, Dirk-Jan Eikema, Sr., Joe Tuffnell, Sr., Victoria Potter, Krzysztof Kalwak, Sr., Stijn Halkes, Sr., Aleksandr Kulagin, Sr., Matthew P. Collin, Sr., Robert Wynn, Sr., Stephen Robinson, Jr., Emma Nicholson, Sr., Henrik Sengeloev, Jennifer Clay, Sr., Khaled Halahleh, Sr., Elena Skorobogatova, Sr., Jakob Passweg, Sr., Stephan Mielke, Samppa Ryhanen, Sr., Ben Carpenter, Tobias Gedde-Dahl, Eleni Tholouli, Renato Fanin, Philippe Lewalle, Sr., Austin Kulasekararaj, Antonio M Risitano, Regis Peffault De Latour
Journal: Blood
Blood (2023) 142 (Supplement 1): 1047.
https://doi.org/10.1182/blood-2023-174724
Published: 2023
Journal Articles

ATG or Post-Transplant Cyclophosphamide to Prevent Gvhd in Matched Unrelated Stem Cell Transplantation? - a Registry Analysis By the EBMT Transplant Complications Working Party

Olaf Penack, Mouad Abouqateb, Christophe Peczynski, William Boreland, Nicolaus Kröger, Matthias Stelljes, Tobias Gedde-Dahl, Igor Wolfgang Blau, Thomas Schroeder, Urpu Salmenniemi, Aleksandr Kulagin, Sr., Regis Peffault De Latour, Stephan Mielke, Jürgen Finke, Ivan Sergeevich Moiseev, Helene Schoemans, Christian Koenecke, Zinaida Peric
Journal: Blood
Blood (2023) 142 (Supplement 1): 3558.
https://doi.org/10.1182/blood-2023-180504
Published: 2023
Journal Articles

Prognostic Factors Impacting Post-Transplant Outcomes in Adult T-Cell Acute Lymphoblastic Leukemia: A Registry-Based Study By the EBMT Acute Leukemia Working Party

Jean Elcheikh, Maud Ngoya, Jacques-Emmanuel Galimard, Péter Reményi, Aleksandr Kulagin, Sr., Mahmoud Aljurf, Ashrafsadat Mousavi, Depei Wu, Mutlu Arat, Urpu Salmenniemi, Cristina Castilla-Llorente, Gerard Socié, Grzegorz Helbig, Thomas Schröder, Ioanna Sakellari, Alessandro Rambaldi, Ben Carpenter, Alessandro Busca, Helene Labussiere Wallet, Matthias Stelljes, Eolia Brissot, Sebastian Giebel, Zina Peric, Arnon Nagler, Fabio Ciceri, Ali Bazarbachi, Mohamad Mohty
Journal: Blood
Blood (2023) 142 (Supplement 1): 2237.
https://doi.org/10.1182/blood-2023-180686
Published: 2023
Journal Articles

Phase III Clinical Trial of Elizaria® and Soliris® in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria: Results of Comparative Analysis of Efficacy, Safety, and Pharmacological Data

Aleksandr Kulagin, Vadim Ptushkin, MD PhD Professor, Elena Lukina, MD PhD Professor, Elena Gapchenko, MD, Oksana Markova, MD MSc, Eugene Zuev, MD, Dmitry Kudlay, MD PhD Professor
Journal: Blood
Blood (2019) 134 (Supplement_1): 3748.
https://doi.org/10.1182/blood-2019-125693
Published: 2019
Journal Articles

Benefits and Limitations of Long-Term Eculizumab Treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH): Real-World Data from Large Cohort Study in Russia

Aleksandr Kulagin, Olesya Klimova, Tatiana Rudakova, Irina Golubovskaya, Maria Ivanova, Anna Smirnova, Alexandra Lapina, Tatiana Bykova, Elena Babenko, Marina Popova, Vladimir Dobronravov, Boris Afanasyev
Journal: Blood
Blood (2018) 132 (Supplement 1): 2589.
https://doi.org/10.1182/blood-2018-99-120139
Published: 2018
Journal Articles

Prognostic Value of Clone Size in Paroxysmal Nocturnal Hemoglobinuria (PNH) for Thrombotic Events in Untreated Patients in the International PNH Registry

Regis Peffault De Latour, Jaroslaw P. Maciejewski, Austin G. Kulasekararaj, MBBS, MD MRCP, FRCPath, Loree Larratt, MD FRCP(C), Ronald S. Go, MD, David Dingli, MD PhD, Amanda Wilson, PhD, Philippe Gustovic, MD, Aleksandr Kulagin
Journal: Blood
Blood (2018) 132 (Supplement 1): 1038.
https://doi.org/10.1182/blood-2018-99-111324
Published: 2018
Journal Articles

Ravulizumab (ALXN1210) Versus Eculizumab in Adults with Paroxysmal Nocturnal Hemoglobinuria: Pharmacokinetics and Pharmacodynamics Observed in Two Phase 3 Randomized, Multicenter Studies

Regis Peffault De Latour, Robert A. Brodsky, MD, Stephan Ortiz, RPh, PhD, Antonio M. Risitano, MD PhD, Jun-Ho Jang, MD PhD, Peter Hillmen, MB ChB, PhD FRCP, FRCPath, Aleksandr Kulagin, Rajendra Pradhan, PhD, Scott T. Rottinghaus, MD, Rasha Aguzzi, MS, Richard A. Wells, MD DPhil, Jeffrey Szer, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 626.
https://doi.org/10.1182/blood-2018-99-110858
Published: 2018
Journal Articles

A Phase 3 Study of Ravulizumab (ALXN1210) Versus Eculizumab in Adults with Paroxysmal Nocturnal Hemoglobinuria Naive to Complement Inhibitors: Results of a Subgroup Analysis with Patients Stratified By Baseline Hemolysis Level, Transfusion History, and Demographics

Ilene C. Weitz, MD, Aleksandr Kulagin, Shinji Nakao, MD PhD, Caroline I. Piatek, MD, Jeffrey Szer, MBBS, Scott T. Rottinghaus, MD, Lori Volles, MD, Andrew I. Damokosh, PhD, Rasha Aguzzi, MS, Loree Larratt, MD, Antonio M. Risitano, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 627.
https://doi.org/10.1182/blood-2018-99-110623
Published: 2018